BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 39
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10205)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.
Item 
Count 
PDF718
WORD304
HTML5859
Tables (1-1)99
 Sum=6980
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse705
Download613
 Sum=1318
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1199
Download708
 Sum=1907
Oct 21, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Kelley CE, Brown AJ, Diehl AM, Setji TL. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol 2014; 20(39): 14172-14184 [PMID: 25339805 DOI: 10.3748/wjg.v20.i39.14172]
URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14172.htm
Number Citing Articles
1
Xinyu Hong, Zaixin Guo, Qi Yu. Hepatic steatosis in women with polycystic ovary syndrome. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01456-6
2
W.-Y. Cai, J.-S. Gao, X. Luo, H.-L. Ma, H. Ge, N. Liu, Q. Xia, Y. Wang, B.-W. Han, X.-K. Wu. Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial. Journal of Endocrinological Investigation 2019; 42(5): 549 doi: 10.1007/s40618-018-0953-6
3
Nicolás Salva-Pastor, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Jorge Román Audifred-Salomón, Danniela Niebla-Cárdenas, Rafael Topete-Estrada, Helga Pereznuñez-Zamora, Rafael Vidaltamayo-Ramírez, Margarita Elodia Báez-Arellano, Misael Uribe, Natalia Nuño-Lámbarri. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Annals of Hepatology 2020; 19(3): 251 doi: 10.1016/j.aohep.2020.01.004
4
A. L. L. Rocha, L. C. Faria, T. C. M. Guimarães, G. V. Moreira, A. L. Cândido, C. A. Couto, F. M. Reis. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. Journal of Endocrinological Investigation 2017; 40(12): 1279 doi: 10.1007/s40618-017-0708-9
5
Jianhai Zhang, Jian Hu, Chunxia Zhang, Yanni Jiao, Xiang Kong, Wei Wang. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5932
6
Raksha Rani, Younis Ahmad Hajam, Rajesh Kumar, Rouf Ahmad Bhat, Seema Rai, Manzoor Ahmad Rather. A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS). Phytomedicine Plus 2022; 2(1): 100161 doi: 10.1016/j.phyplu.2021.100161
7
Parisa Sadat Pournaderi, Parichehreh Yaghmaei, Hamidreza Khodaei, Zahra Noormohammadi, Seyed Hossein Hejazi. The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate – Induced polycystic ovary syndrome in Wistar rats. Biochemical and Biophysical Research Communications 2017; 484(2): 461 doi: 10.1016/j.bbrc.2017.01.057
8
Lihong Liu, Bo Du, Haiying Zhang, Xiaofei Guo, Zheng Zhou, Aihui Xiu, Chang Liu, Shiyu Su, Hao Ai. A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome. Chinese Medicine 2018; 13(1) doi: 10.1186/s13020-018-0201-1
9
Z. Esmaeilinezhad, S. Babajafari, Z. Sohrabi, M.-H. Eskandari, S. Amooee, R. Barati-Boldaji. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(2): 201 doi: 10.1016/j.numecd.2018.07.002
10
Linjie Chen, Zhifen Zhang, Jian Huang, Minjuan Jin. Association between rs1800795 polymorphism in the interleukin-6 gene and the risk of polycystic ovary syndrome. Medicine 2018; 97(29): e11558 doi: 10.1097/MD.0000000000011558
11
Avni Mody, Donna White, Fasiha Kanwal, Jose M. Garcia. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 2015; 4(3): 83 doi: 10.1097/XCE.0000000000000057
12
Filomena Morisco, Raffaele Bruno, Elisabetta Bugianesi, Patrizia Burra, Vincenza Calvaruso, Alice Cannoni, Nicola Caporaso, Gian Paolo Caviglia, Alessia Ciancio, Silvia Fargion, Alessandro Federico, Annarosa Floreani, Giovanni Battista Gaeta, Maria Guarino, Pietro Invernizzi, Anna Licata, Carmela Loguercio, Giuseppe Mazzella, Felice Petraglia, Massimo Primignani, Kryssia Rodriguez-Castro, Antonina Smedile, Luca Valenti, Ester Vanni, Silvia Vannuccini, Chiara Voltolini, Erica Villa. AISF position paper on liver disease and pregnancy. Digestive and Liver Disease 2016; 48(2): 120 doi: 10.1016/j.dld.2015.11.004
13
Mariana Lazo, Irfan Zeb, Khurram Nasir, Russell P. Tracy, Matthew J. Budoff, Pamela Ouyang, Dhananjay Vaidya. Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clinical Gastroenterology and Hepatology 2015; 13(9): 1686 doi: 10.1016/j.cgh.2014.12.033
14
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. Journal of Clinical and Experimental Hepatology 2020; 10(1): 81 doi: 10.1016/j.jceh.2019.07.008
15
Suvarthi Das, Firas Alhasson, Diptadip Dattaroy, Sahar Pourhoseini, Ratanesh Kumar Seth, Mitzi Nagarkatti, Prakash S. Nagarkatti, Gregory A. Michelotti, Anna Mae Diehl, Balaraman Kalyanaraman, Saurabh Chatterjee. NADPH Oxidase–Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. The American Journal of Pathology 2015; 185(7): 1944 doi: 10.1016/j.ajpath.2015.03.024
16
Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786
17
Saurabh Chatterjee, Suvarthi Das. P2X7 Receptor as a Key Player in Oxidative Stress-Driven Cell Fate in Nonalcoholic Steatohepatitis. Oxidative Medicine and Cellular Longevity 2015; 2015: 1 doi: 10.1155/2015/172493
18
Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Siwanart Kongarin, Karan Srisurapanont, Phakkamon Pingwang, Nonlawan Songmueang, Chalida Nonthasoot, Worapaka Manosroi, Surakit Nathisuwan, Fang Li, Ju Dong Yang, Vincent L. Chen, Donghee Kim, Mazen Noureddin, Daniel Q. Huang, Karn Wijarnpreecha. Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women. Mayo Clinic Proceedings 2024;  doi: 10.1016/j.mayocp.2023.12.025
19
Eda Kaya, Yusuf Yilmaz. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Journal of Clinical and Translational Hepatology 2022; 10(2): 329 doi: 10.14218/JCTH.2021.00178
20
Monika Sarkar, Melissa Wellons, Marcelle I Cedars, Lisa VanWagner, Erica P Gunderson, Veeral Ajmera, Laura Torchen, David Siscovick, Jeffrey J Carr, James G Terry, Mary Rinella, Cora E Lewis, Norah Terrault. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. American Journal of Gastroenterology 2017; 112(5): 755 doi: 10.1038/ajg.2017.44
21
Sikandar Hayat Khan, Farah Sobia, Najmusaqib Khan Niazi, Syed Mohsin Manzoor, Nadeem Fazal, Fowad Ahmad. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetology & Metabolic Syndrome 2018; 10(1) doi: 10.1186/s13098-018-0376-8
22
Alirez Sadeghi, Kurosh Djafarian, Hamed Mohammadi, Sakineh Shab-Bidar. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11(2): 157 doi: 10.1016/j.dsx.2016.06.025
23
Jéssica A. G. Tosatti, Michelle T. Alves, Ana L. Cândido, Fernando M. Reis, Vânia E. Araújo, Karina B. Gomes. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. British Journal of Nutrition 2021; 125(6): 657 doi: 10.1017/S0007114520003207
24
Claire Falzarano, Taylor Lofton, Adjoa Osei-Ntansah, Trinitee Oliver, Taylor Southward, Salim Stewart, Stanley Andrisse. Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 2022; 107(1): 258 doi: 10.1210/clinem/dgab658
25
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
26
Abdulrahman Ismaiel, Piero Portincasa, Dan L. Dumitrascu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 19 doi: 10.1007/978-3-031-33548-8_3
27
Xusong Hu, Xuechun Weng, Ye Tian, Chengtao Wang, Yanzhou Yang, Kaili Xu, Cheng Zhang. Effects of omega-3 polyunsaturated fatty acids on steroidogenesis and cellular development in PCOS rats. Food & Function 2019; 10(5): 2504 doi: 10.1039/C8FO02319K
28
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>&reg;</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
29
Ratan Dasgupta. Growth Curve Models and Applications. Springer Proceedings in Mathematics & Statistics 2017; 204: 91 doi: 10.1007/978-3-319-63886-7_3
30
Dejana Rakic, Vladimir Jakovljevic, Nikola Jovic, Marija Bicanin Ilic, Aleksandra Dimitrijevic, Tatjana Vulovic, Petar Arsenijevic, Jasmina Sretenovic, Maja Nikolic, Vladimir Petrovich Fisenko, Stefani Bolevich, Gala Zarkovic, Jovana Joksimovic Jovic. The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives. Biomedicines 2023; 11(4): 998 doi: 10.3390/biomedicines11040998
31
Marieke Tebbens, Moya Schutte, Marian A Troelstra, Eveline Bruinstroop, Renée de Mutsert, Aart J Nederveen, Martin den Heijer, Peter H Bisschop. Sex Steroids Regulate Liver Fat Content and Body Fat Distribution in Both Men and Women: A Study in Transgender Persons. The Journal of Clinical Endocrinology & Metabolism 2023; 109(1): e280 doi: 10.1210/clinem/dgad409
32
Rashmi Kudesia, Hina J. Talib, Staci E. Pollack. Fertility Awareness Counseling for Adolescent Girls; Guiding Conception: The Right Time, Right Weight, and Right Way. Journal of Pediatric and Adolescent Gynecology 2017; 30(1): 9 doi: 10.1016/j.jpag.2016.07.004
33
Michael Freemark. Pediatric Obesity. Contemporary Endocrinology 2018; : 323 doi: 10.1007/978-3-319-68192-4_19
34
M. A. Livzan, O. V. Gaus, N. A. Nikolaev, T. S. Krolevetz. NAFLD: comorbidity and associated diseases. Experimental and Clinical Gastroenterology 2020; 1(10): 57 doi: 10.31146/1682-8658-ecg-170-10-57-65
35
Minqian Shen, Haifei Shi. Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/294278
36
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
37
Unaiza Qamar, Stephen L. Atkin, Thozhukat Sathyapalan. Practical Guide to Obesity Medicine. 2018; : 59 doi: 10.1016/B978-0-323-48559-3.00006-3
38
HafejaAkhter Hima, MdAbdul Hannan Miah, NipaRani Ghosh, Sazia Sultana, Tanjina Akter, FatemaTuz Zahura Aalpona, AB. M. Kamrul-Hasan. Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in Bangladesh. Bangladesh Journal of Endocrinology and Metabolism 2023; 2(2): 80 doi: 10.4103/bjem.bjem_10_23
39
Kailin Yang, Liuting Zeng, Tingting Bao, Jinwen Ge. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology 2018; 16(1) doi: 10.1186/s12958-018-0346-x
40
Andrew A. Li, Aijaz Ahmed, Donghee Kim. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Gut and Liver 2020; 14(2): 168 doi: 10.5009/gnl19069
41
Ratan Dasgupta, Anwesha Pan. Growth Curve and Structural Equation Modeling. Springer Proceedings in Mathematics & Statistics 2015; 132: 135 doi: 10.1007/978-3-319-17329-0_8
42
Sambit Roy, Aierken Abudu, Irving Salinas, Niharika Sinha, Holly Cline-Fedewa, Alexandra M Yaw, Wenjie Qi, Todd A Lydic, Diana L Takahashi, Jon D Hennebold, Hanne M Hoffmann, Jianrong Wang, Aritro Sen. Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice. Endocrinology 2022; 163(10) doi: 10.1210/endocr/bqac127
43
Tsung-Sheng Chen, Yi-Ting Chen, Chia-Hsin Liu, Chi-Ching Sun, Frank Chiahung Mao. Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS. Gynecological Endocrinology 2017; 33(1): 48 doi: 10.1080/09513590.2016.1205579
44
Aikaterini Giannouli, Vasiliki Efthymiou, Marianna Konidari, Iliana Mani, Leon Aravantinos, Spyridon P. Dourakis, Aristeidis Antoniou, Efthymios Deligeoroglou, Flora Bacopoulou. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study. Journal of Clinical Medicine 2023; 12(2): 557 doi: 10.3390/jcm12020557
45
HAOYU KUANG, XIAOLI HUA, JIANHUI ZHOU, RUI YANG. Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity. Oncology Reports 2016; 35(1): 307 doi: 10.3892/or.2015.4389
46
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00051
47
Xiaoshu Ma, Xuechun Weng, Xusong Hu, Qiaozhi Wang, Ye Tian, Yu Ding, Cheng Zhang. Roles of different n-3/n-6 PUFA ratios in ovarian cell development and steroidogenesis in PCOS rats. Food & Function 2019; 10(11): 7397 doi: 10.1039/C9FO01730E
48
Devaraj Ezhilarasan. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2020; 19(5): 429 doi: 10.1016/j.hbpd.2020.03.011
49
Luca Valenti, Stefano Romeo. Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood. Journal of Hepatology 2016; 65(4): 668 doi: 10.1016/j.jhep.2016.06.010
50
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1): 73 doi: 10.3892/etm.2015.2873
51
Giovanni Targher, Maurizio Rossini, Amedeo Lonardo. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?. Endocrine 2016; 51(2): 211 doi: 10.1007/s12020-015-0640-8
52
Zhao-Chun Chi. Research status and progress of metabolic associated fatty liver disease. World Chinese Journal of Digestology 2022; 30(1): 1 doi: 10.11569/wcjd.v30.i1.1
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
53
Yong Chen, Leikai Ma, Zhouling Ge, Yizhao Pan, Lubin Xie. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.888194
54
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry. Diabetes, Metabolic Syndrome and Obesity 2023; : 3115 doi: 10.2147/DMSO.S430740
55
Masataka Seike. The Liver in Systemic Diseases. 2016; : 251 doi: 10.1007/978-4-431-55790-6_12
56
Chunwei Walter Lai, Sneha Jadhav, Basile Njei, Aijun Ye, Jean Wactawski-Wende, Sunni L. Mumford, Enrique F. Schisterman, Yaron Rotman. Rhythmic Fluctuations in Levels of Liver Enzymes During Menstrual Cycles of Healthy Women and Effects of Body Weight. Clinical Gastroenterology and Hepatology 2020; 18(9): 2055 doi: 10.1016/j.cgh.2019.11.047
57
Juan Wang, Daichao Wu, Hui Guo, Meixiang Li. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences 2019; 236: 116940 doi: 10.1016/j.lfs.2019.116940
58
Ilay Gozukara, Recep Dokuyucu, Tümay Özgür, Oguzhan Özcan, Neslihan Pınar, Raziye Keskin Kurt, Suna Kabil Kucur, Kenan Dolapcioglu. Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model. Gynecological Endocrinology 2016; 32(6): 492 doi: 10.3109/09513590.2015.1134478
59
Lisa B. VanWagner, Mary E. Rinella. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2): 75 doi: 10.1007/s11901-016-0295-9
60
Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises 2024; 82(3): 373 doi: 10.1016/j.pharma.2024.02.005
61
Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Pegah Golabi, Linda Henry, Zobair M. Younossi. Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis. Journal of Clinical Gastroenterology 2017; 51(3): 254 doi: 10.1097/MCG.0000000000000567
62
Kara Wegermann, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan. REPLY:. Hepatology 2021; 73(4): 1625 doi: 10.1002/hep.31593
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345